In-Stent Restenosis Clinical Trial
Official title:
RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent). A Prospective, Multicenter and Randomized Clinical Trial
Treatment of patients with bare metal stent restenosis remains a challenge. This study will assess which interventional strategy (paclitaxel-eluting balloon vs everolimus-eluting stent) is superior in the treatment of patients suffering from bare metal stent restenosis.
Treatment of patients with bare metal stent restenosis remains a major clinical and
technical challenge. Currently, drug-eluting stents are widely used in the management of
these patients. Recently, the value of the paclitaxel-eluting balloon in this clinical
setting has been suggested. However, there is only scarce observational data on the value of
this new balloon in patients with bare metal stent restenosis.
This prospective, multicenter, randomized clinical trial will compare two different
interventional strategies (namely, paclitaxel-eluting balloon vs everolimus-eluting stent)
in the treatment of patients with bare metal stent restenosis.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00341562 -
Genomics of In-Stent Restenosis
|
N/A | |
| Completed |
NCT05509296 -
Compare the Effectiveness and Safety of Two Different Kinds of Cutting Balloon in Coronary Artery Disease
|
N/A | |
| Not yet recruiting |
NCT06090890 -
Anti-inflammatory Therapy for Recurrent In-stent Restenosis
|
Phase 4 | |
| Active, not recruiting |
NCT00998439 -
Treatment of Drug-eluting Stent (DES) In-Stent Restenosis With SeQuent® Please Paclitaxel Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter
|
Phase 2 | |
| Active, not recruiting |
NCT05731700 -
CVT-ISR First in Human Trial for Coronary In-Stent Restenosis
|
N/A | |
| Completed |
NCT03260517 -
The PREVAIL Study
|
N/A | |
| Not yet recruiting |
NCT03588962 -
Metal Allergy In-Stent Restenosis Study
|
N/A | |
| Completed |
NCT00393315 -
P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses
|
Phase 2 | |
| Recruiting |
NCT03874481 -
The Effect of Sleep Quality on Coronary Artery Disease and In Stent Restenosis
|
||
| Active, not recruiting |
NCT01127958 -
DARE-trial: A Trial Studying the Effect of the SeQuent Please Drug-eluting Balloon Compared to the Xience Prime Drug-eluting Stent for the Treatment of Stenosis of an Earlier Implanted Stent.
|
N/A | |
| Active, not recruiting |
NCT04647253 -
A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)
|
Phase 3 | |
| Active, not recruiting |
NCT03529006 -
Absorb Bioresorbable Scaffold vs. Drug Coated Balloon for Treatment Of In-Stent-Restenosis
|
N/A | |
| Completed |
NCT00485030 -
Diffuse Type In-Stent Restenosis After Drug-Eluting Stent
|
Phase 4 | |
| Not yet recruiting |
NCT03809754 -
Optical Coherence Tomography Guided Percutaneous Coronary Intervention for Drug-eluting In-stent Restenosis
|
N/A | |
| Completed |
NCT00916279 -
PERVIDEO I Registry, The Lutonix Paclitaxel-Coated Balloon Catheter for the Treatment of Coronary In-Stent Restenosis
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05473884 -
Lesion Preparation in Femoropopliteal Artery Occlusion Disease
|
||
| Recruiting |
NCT01239940 -
RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)
|
Phase 4 | |
| Not yet recruiting |
NCT06148441 -
Role of Novel Biomarkers Associated With In-stent Restenosis After Percutaneous Coronary Intervention
|
||
| Completed |
NCT05512832 -
In-stent Restenosis and Pericoronary Fat Attenuation Index
|
||
| Recruiting |
NCT03521843 -
LDD in Treatment of Femoropopliteal ISR
|
N/A |